Skip to main content

Dr. Steven D. Nathan, MD

Pulmonology (Pulmonary Disease Physician)

  • Medicare participating

At a glance

Years since graduation
45
In the NPI registry since
2006
Medicare patients seen, 2024
111

The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is

Education and training

  • 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier

Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).

Specialties and state licenses

  • Pulmonary Disease Physician primary
    VA license 0101050649
  • Critical Care Medicine (Internal Medicine) Physician
    VA license 0101050649
  • Internal Medicine Physician
    VA license 0101050649

As reported to the NPI registry. To confirm a license is current, check the state medical board.

Map: Pulmonology per capita by county →

Where they work

Hospitals

Medical groups

Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.

Medicare patients and services

Medicare patients, 2024
111
Services billed
215
Patients’ average age
75
Most frequent Medicare services, 2023
ServiceTimesPatients
Established patient office or other outpatient visit, 40-54 minutes13586
New patient office or other outpatient visit, 60-74 minutes2727
Established patient office or other outpatient visit, 30-39 minutes1917

Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.

Medicare prescriptions

Most prescribed drugs, Medicare Part D 2024
DrugPrescriptions
Ofev (nintedanib esylate)199
Prednisone
Other prescribers in Falls Church, VA
64
Pirfenidone45
Tyvaso Dpi (treprostinil)37
Opsumit (macitentan)35
Albuterol Sulfate Hfa (albuterol sulfate)
Other prescribers in Falls Church, VA
26
Furosemide
Other prescribers in Falls Church, VA
21
Mycophenolate Mofetil
Other prescribers in Falls Church, VA
20
Fluticasone Propionate
Other prescribers in Falls Church, VA
18
Tadalafil15

Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.

Payments from drug and device companies

In 2025, 19 companies reported 248 payments worth $240,520 in total to this clinician.

By type
Consulting Fee$132,851
Compensation for services other than consulting (speaking, faculty)$81,670
Travel and Lodging$20,219
Food and Beverage$5,780

What the payments were for

Largest payments other than meals
DateCompanyWhat it was forAmount
Jun 16, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Jun 16, 2025
Consulting Fee$13,370
Dec 15, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 15, 2025
Consulting Fee$11,700
Apr 3, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 3, 2025
Consulting Fee$11,460
Apr 3, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 3, 2025
Consulting Fee$10,505
Jan 31, 2025United Therapeutics Corporation
Jan 31, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$8,200
Aug 8, 2025United Therapeutics Corporation
Aug 8, 2025
Consulting Fee
REMODULIN · Pulmonary Arterial Hypertension
$8,200
Apr 16, 2025United Therapeutics Corporation
Apr 16, 2025
Compensation for services other than consulting (speaking, faculty)
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$7,260
Jul 25, 2025United Therapeutics Corporation
Jul 25, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$6,950
Oct 27, 2025United Therapeutics Corporation
Oct 27, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$6,930
Mar 28, 2025United Therapeutics Corporation
Mar 28, 2025
Compensation for services other than consulting (speaking, faculty)$6,600
All 122 payments other than meals, newest first
All payments other than meals
DateCompanyWhat it was forAmount
Dec 30, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 30, 2025
Compensation for services other than consulting (speaking, faculty)$6,340
Dec 30, 2025United Therapeutics Corporation
Dec 30, 2025
Travel and Lodging
travel to Maywood, IL · in-kind
$504
Dec 19, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 19, 2025
Consulting Fee$3,900
Dec 15, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 15, 2025
Consulting Fee$11,700
Dec 15, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 15, 2025
Travel and Lodging
travel to Washington, DC · in-kind
$106
Dec 11, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 11, 2025
Compensation for services other than consulting (speaking, faculty)
OFEV · RESPIRATORY
$6,340
Dec 11, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 11, 2025
Compensation for services other than consulting (speaking, faculty)
OFEV · RESPIRATORY
$6,340
Dec 11, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 11, 2025
Travel and Lodging
OFEV · RESPIRATORY · travel to Roanoke, VA · in-kind
$1,268
Dec 8, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 8, 2025
Compensation for services other than consulting (speaking, faculty)
OFEV · RESPIRATORY
$6,340
Dec 8, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 8, 2025
Compensation for services other than consulting (speaking, faculty)
OFEV · RESPIRATORY
$2,440
Dec 4, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 4, 2025
Travel and Lodging
OFEV · RESPIRATORY · travel to Springfield, MA · in-kind
$1,344
Dec 4, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 4, 2025
Travel and Lodging
OFEV · RESPIRATORY · travel to Springfield, MA · in-kind
$332
Dec 3, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Dec 3, 2025
Consulting Fee$5,850
Nov 19, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Nov 19, 2025
Travel and Lodging
travel to Norfolk, VA · in-kind
$1,632
Nov 13, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Nov 13, 2025
Consulting Fee$3,900
Nov 13, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Nov 13, 2025
Travel and Lodging
travel to Philadelphia, PA · in-kind
$646
Nov 13, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Nov 13, 2025
Travel and Lodging
travel to Philadelphia, PA · in-kind
$301
Nov 12, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Nov 12, 2025
Travel and Lodging
travel to Rehoboth Beach, DE · in-kind
$1,199
Oct 30, 2025E.r. Squibb & Sons, L.l.c.
Oct 30, 2025
Consulting Fee$1,375
Oct 27, 2025United Therapeutics Corporation
Oct 27, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$6,930
Oct 27, 2025United Therapeutics Corporation
Oct 27, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Chicago, IL
$329
Oct 20, 2025Boehringer Ingelheim International GmbH
Oct 20, 2025
Consulting Fee$3,600
Oct 20, 2025Boehringer Ingelheim International GmbH
Oct 20, 2025
Travel and Lodging
travel to Amsterdam, Netherlands · in-kind
$46.34
Oct 16, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Oct 16, 2025
Travel and Lodging
travel to Chicago, IL · in-kind
$330
Oct 10, 2025United Therapeutics Corporation
Oct 10, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$1,890
Oct 8, 2025United Therapeutics Corporation
Oct 8, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$580
Oct 6, 2025United Therapeutics Corporation
Oct 6, 2025
Compensation for services other than consulting (speaking, faculty)$2,640
Oct 2, 2025United Therapeutics Corporation
Oct 2, 2025
Compensation for services other than consulting (speaking, faculty)$5,280
Sep 29, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Sep 29, 2025
Compensation for services other than consulting (speaking, faculty)$2,390
Sep 24, 2025United Therapeutics Corporation
Sep 24, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$315
Sep 12, 2025United Therapeutics Corporation
Sep 12, 2025
Compensation for services other than consulting (speaking, faculty)
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$3,960
Sep 4, 2025United Therapeutics Corporation
Sep 4, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Greenville, NC
$1,294
Aug 28, 2025United Therapeutics Corporation
Aug 28, 2025
Travel and Lodging
travel to Miami, FL
$205
Aug 28, 2025United Therapeutics Corporation
Aug 28, 2025
Travel and Lodging
travel to Miami, FL
$63.00
Aug 28, 2025United Therapeutics Corporation
Aug 28, 2025
Travel and Lodging
travel to Miami, FL · in-kind
$53.50
Aug 20, 2025United Therapeutics Corporation
Aug 20, 2025
Travel and Lodging
travel to Miami, FL · in-kind
$198
Aug 15, 2025United Therapeutics Corporation
Aug 15, 2025
Travel and Lodging
travel to Miami, FL · in-kind
$230
Aug 15, 2025United Therapeutics Corporation
Aug 15, 2025
Travel and Lodging
travel to Miami, FL · in-kind
$40.31
Aug 13, 2025United Therapeutics Corporation
Aug 13, 2025
Compensation for services other than consulting (speaking, faculty)
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$1,270
Aug 13, 2025United Therapeutics Corporation
Aug 13, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$870
Aug 13, 2025United Therapeutics Corporation
Aug 13, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$473
Aug 8, 2025United Therapeutics Corporation
Aug 8, 2025
Consulting Fee
REMODULIN · Pulmonary Arterial Hypertension
$8,200
Aug 8, 2025United Therapeutics Corporation
Aug 8, 2025
Travel and Lodging
REMODULIN · Pulmonary Arterial Hypertension · travel to Dallas, TX
$42.00
Aug 7, 2025United Therapeutics Corporation
Aug 7, 2025
Travel and Lodging
REMODULIN · Pulmonary Arterial Hypertension · travel to Dallas, TX · in-kind
$377
Aug 7, 2025United Therapeutics Corporation
Aug 7, 2025
Travel and Lodging
REMODULIN · Pulmonary Arterial Hypertension · travel to Dallas, TX · in-kind
$345
Aug 7, 2025United Therapeutics Corporation
Aug 7, 2025
Travel and Lodging
REMODULIN · Pulmonary Arterial Hypertension · travel to Dallas, TX
$24.98
Aug 1, 2025United Therapeutics Corporation
Aug 1, 2025
Compensation for services other than consulting (speaking, faculty)
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$5,280
Jul 30, 2025AbbVie Inc.
Jul 30, 2025
Consulting Fee$488
Jul 29, 2025United Therapeutics Corporation
Jul 29, 2025
Compensation for services other than consulting (speaking, faculty)
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$2,640
Jul 28, 2025United Therapeutics Corporation
Jul 28, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX
$165
Jul 28, 2025United Therapeutics Corporation
Jul 28, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX
$42.00
Jul 28, 2025United Therapeutics Corporation
Jul 28, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX · in-kind
$10.00
Jul 28, 2025United Therapeutics Corporation
Jul 28, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX
$10.00
Jul 25, 2025United Therapeutics Corporation
Jul 25, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$6,950
Jul 24, 2025United Therapeutics Corporation
Jul 24, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Detroit, MI · in-kind
$384
Jul 24, 2025United Therapeutics Corporation
Jul 24, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Detroit, MI · in-kind
$298
Jul 24, 2025United Therapeutics Corporation
Jul 24, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Detroit, MI
$42.00
Jul 18, 2025United Therapeutics Corporation
Jul 18, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX · in-kind
$216
Jul 16, 2025United Therapeutics Corporation
Jul 16, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$1,575
Jul 9, 2025United Therapeutics Corporation
Jul 9, 2025
Compensation for services other than consulting (speaking, faculty)$1,270
Jul 7, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Jul 7, 2025
Consulting Fee$5,730
Jul 7, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Jul 7, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$444
Jul 3, 2025AbbVie Inc.
Jul 3, 2025
Consulting Fee$2,275
Jun 25, 2025AbbVie Inc.
Jun 25, 2025
Consulting Fee$2,438
Jun 24, 2025United Therapeutics Corporation
Jun 24, 2025
Travel and Lodging
travel to Miami, FL · in-kind
$103
Jun 24, 2025United Therapeutics Corporation
Jun 24, 2025
Travel and Lodging
travel to Miami, FL · in-kind
$40.31
Jun 18, 2025United Therapeutics Corporation
Jun 18, 2025
Compensation for services other than consulting (speaking, faculty)
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$1,270
Jun 16, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Jun 16, 2025
Consulting Fee$13,370
Jun 16, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Jun 16, 2025
Consulting Fee$4,775
Jun 16, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Jun 16, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$140
Jun 12, 2025United Therapeutics Corporation
Jun 12, 2025
Compensation for services other than consulting (speaking, faculty)
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$1,270
Jun 9, 2025E.r. Squibb & Sons, L.l.c.
Jun 9, 2025
Consulting Fee$1,194
Jun 5, 2025Boehringer Ingelheim International GmbH
Jun 5, 2025
Consulting Fee$1,200
Jun 4, 2025E.r. Squibb & Sons, L.l.c.
Jun 4, 2025
Consulting Fee$5,520
May 22, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
May 22, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$139
May 19, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
May 19, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$150
May 16, 2025United Therapeutics Corporation
May 16, 2025
Travel and Lodging
travel to Miami, FL · in-kind
$103
May 16, 2025United Therapeutics Corporation
May 16, 2025
Travel and Lodging
travel to Miami, FL · in-kind
$15.91
May 16, 2025United Therapeutics Corporation
May 16, 2025
Travel and Lodging
travel to Fort Lauderdale, FL · in-kind
$15.91
May 14, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
May 14, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$444
May 13, 2025E.r. Squibb & Sons, L.l.c.
May 13, 2025
Consulting Fee$1,238
Apr 30, 2025Argenx US, Inc.
Apr 30, 2025
Consulting Fee$338
Apr 18, 2025United Therapeutics Corporation
Apr 18, 2025
Travel and Lodging
travel to Dallas, TX
$42.00
Apr 18, 2025United Therapeutics Corporation
Apr 18, 2025
Travel and Lodging
travel to Dallas, TX
$14.00
Apr 16, 2025United Therapeutics Corporation
Apr 16, 2025
Compensation for services other than consulting (speaking, faculty)
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$7,260
Apr 16, 2025United Therapeutics Corporation
Apr 16, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Leominster, MA
$60.70
Apr 10, 2025United Therapeutics Corporation
Apr 10, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Leominster, MA · in-kind
$219
Apr 9, 2025United Therapeutics Corporation
Apr 9, 2025
Compensation for services other than consulting (speaking, faculty)$5,940
Apr 3, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 3, 2025
Consulting Fee$11,460
Apr 3, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 3, 2025
Consulting Fee$10,505
Apr 3, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 3, 2025
Travel and Lodging
travel to Fort Worth, TX · in-kind
$140
Apr 3, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 3, 2025
Travel and Lodging
travel to Fort Worth, TX · in-kind
$140
Apr 2, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 2, 2025
Travel and Lodging
travel to Fort Worth, TX · in-kind
$224
Apr 2, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 2, 2025
Travel and Lodging
travel to Fort Worth, TX · in-kind
$224
Apr 1, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Apr 1, 2025
Travel and Lodging
travel to San Francisco, CA · in-kind
$517
Mar 28, 2025United Therapeutics Corporation
Mar 28, 2025
Compensation for services other than consulting (speaking, faculty)$6,600
Mar 26, 2025United Therapeutics Corporation
Mar 26, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$4,060
Mar 21, 2025United Therapeutics Corporation
Mar 21, 2025
Travel and Lodging
travel to Denver, CO
$21.00
Mar 21, 2025United Therapeutics Corporation
Mar 21, 2025
Travel and Lodging
travel to Denver, CO
$14.00
Mar 19, 2025United Therapeutics Corporation
Mar 19, 2025
Travel and Lodging
travel to Jackson, TN · in-kind
$465
Mar 17, 2025United Therapeutics Corporation
Mar 17, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Houston, TX · in-kind
$399
Mar 17, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Mar 17, 2025
Travel and Lodging
travel to Fort Worth, TX · in-kind
$146
Mar 5, 2025United Therapeutics Corporation
Mar 5, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Greenville, NC
$15.94
Feb 28, 2025United Therapeutics Corporation
Feb 28, 2025
Travel and Lodging
travel to Dallas, TX · in-kind
$304
Feb 26, 2025E.r. Squibb & Sons, L.l.c.
Feb 26, 2025
Consulting Fee$1,380
Feb 25, 2025United Therapeutics Corporation
Feb 25, 2025
Travel and Lodging
travel to Springfield, MA · in-kind
$345
Feb 17, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Feb 17, 2025
Travel and Lodging
travel to Fort Worth, TX · in-kind
$471
Feb 17, 2025Boehringer Ingelheim Pharmaceuticals, Inc.
Feb 17, 2025
Travel and Lodging
travel to Fort Worth, TX · in-kind
$322
Feb 14, 2025United Therapeutics Corporation
Feb 14, 2025
Travel and Lodging
travel to Denver, CO · in-kind
$313
Feb 11, 2025United Therapeutics Corporation
Feb 11, 2025
Compensation for services other than consulting (speaking, faculty)$3,400
Feb 11, 2025United Therapeutics Corporation
Feb 11, 2025
Travel and Lodging
travel to Chesterfield, MO
$36.98
Feb 7, 2025United Therapeutics Corporation
Feb 7, 2025
Travel and Lodging
travel to Chesterfield, MO · in-kind
$209
Feb 3, 2025United Therapeutics Corporation
Feb 3, 2025
Travel and Lodging
travel to Dallas, TX · in-kind
$642
Jan 31, 2025United Therapeutics Corporation
Jan 31, 2025
Consulting Fee
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun
$8,200
Jan 30, 2025United Therapeutics Corporation
Jan 30, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Dallas, TX · in-kind
$369
Jan 30, 2025United Therapeutics Corporation
Jan 30, 2025
Travel and Lodging
TYVASO · Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lun · travel to Dallas, TX · in-kind
$349
Jan 29, 2025United Therapeutics Corporation
Jan 29, 2025
Compensation for services other than consulting (speaking, faculty)$3,400
Jan 27, 2025United Therapeutics Corporation
Jan 27, 2025
Travel and Lodging
travel to Chesterfield, MO · in-kind
$312
Jan 27, 2025United Therapeutics Corporation
Jan 27, 2025
Travel and Lodging
travel to Charleston, SC
$29.00
Jan 27, 2025United Therapeutics Corporation
Jan 27, 2025
Travel and Lodging
travel to Charleston, SC
$25.20
Jan 17, 2025United Therapeutics Corporation
Jan 17, 2025
Travel and Lodging
travel to Charleston, SC · in-kind
$178
Jan 15, 2025AbbVie Inc.
Jan 15, 2025
Consulting Fee$575

Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.

From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.

Who received the most in Virginia →

Industry-funded research

Named as a principal investigator on 1 industry-funded study in 2025, from 1 company. The companies reported $427,790 in research payments for these studies, mostly to the institutions running them.

From CMS Open Payments research payments, where companies name up to five principal investigators per payment. Research payments usually go to hospitals, universities and research sites, not to the investigator personally. A payment is not evidence of wrongdoing.

Other Pulmonology clinicians in Falls Church

Sources

NPI registry (CMS NPPES, November 2026; record last updated May 11, 2022), Medicare Care Compare, Medicare Physician & Other Practitioners (2024), Medicare Part D Prescribers (2024) and Open Payments (2025). Information is self-reported or billed data and may be out of date; call before visiting.

NPI 1891724134. Official NPI registry record (opens in a new tab). Clinicians can correct their information in NPPES; changes appear here after our next monthly update.